Immunogenic compounds comprising peptides of IL1β
- 专利权人:
- Natacha Bessis;Jean-Francois Zagury;Marie-Christophe Boissier
- 发明人:
- Jean-Francois Zagury,Marie-Christophe Boissier,Natacha Bessis
- 申请号：
- US13004526
- 公开号：
- US08632781B2
- 申请日:
- 2011.01.11
- 申请国别(地区):
- US
- 年份:
- 2014
- 代理人:
- 摘要：
- The present invention relates to peptides derived from the proinflammatory cytokines, interleukin-1β (IL1β) and tumor necrosis factor α (TNFα), and their use in human or veterinary therapy, such as to generally treat diseases linked to the overproduction of IL1β or TNFα as well as acute or chronic inflammatory diseases, rheumatoid arthritis, septic shock, autoimmune diabetes, graft rejection in the host, etc.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Zastosowanie pochodnych aminowych jako inhibitorów aktywności interleukiny 15
- CYTOKINE INHIBITORS
- 소염 활성을 갖는 알파-아미노산 유도체
- method of reducing side effects and method of enhancing the effect of an immunomodulator administered to a subject in need thereof； methods for treating disease associated with overactivation of monocytes to activated macrophages, type II diabetes or related complications, disease associated with migration of activated monocytes or macrophages, disease associated with overproduction of scd14 and / or scd163 by activated macrophages； sodium chloride compound； pharmaceutical composition； method for diagnosing a macrophage-related disease in a subject； and method for determining the effectiveness
- Polypeptides and Antibodies to Treat Skin Conditions Associated with Overproduction of Sebum
